BRCA1 and metabolic disease: This phenomenon was detected in oncogenetics (BRCA1/2 testing), inborn metabolic disease genotyping (FAH testing), hematology research etc (Lam and Mak, 2013; Shmukler et al., 2013; Jeong et al., 2019).